Synulox 500 mg tablets for dogs
Synulox 500 mg tablets for dogs
Authorised
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Synulox 500 mg Comprimés Appétents
Synulox 500 mg tablets for dogs
Active substance:
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Potassium clavulanate119.14/milligram(s)1.00Tablet
-
Amoxicillin trihydrate459.10/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- (ID3) 20 Tablet: Box (board) with 10 Blister (aluminium; low-density polyethylene) each with 2 Tablet
- (ID2) 100 Tablet: Box (board) with 50 Blister (aluminium; low-density polyethylene) each with 2 Tablet
- (ID1) 10 Tablet: Box (board) with 5 Blister (aluminium; low-density polyethylene) each with 2 Tablet
- (ID4) 200 Tablet: Box (board) with 100 Blister (aluminium; low-density polyethylene) each with 2 Tablet
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 087/98/11/0627
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 16/03/2023
Combined File of all Documents
English (PDF)
Download Published on: 2/12/2025